To assess the effect of fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) with contemporary drug-eluting stents on the composite of cardiac death or myocardial infarction (MI) vs. medical therapy in patients with stable coronary lesions.
Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient data / Zimmermann, F.M., Omerovic, E., Fournier, S., Kelbæk, H., Johnson, N.P., Rothenbühler, M., Xaplanteris, P., Abdel-Wahab, M., Barbato, E., Høfsten, D.E., Tonino, P.A.L., Boxma-de Klerk, B.M., Fearon, W.F., Køber, L., Smits, P.C., De Bruyne, B., Pijls, N.H.J., Jüni, P., Engstrøm, T.. - In: EUROPEAN HEART JOURNAL. - ISSN 1522-9645. - 40:2(2019), p. 180-186. [10.1093/eurheartj/ehy812]
Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient data
Barbato, EmanueleMembro del Collaboration Group
;
2019
Abstract
To assess the effect of fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) with contemporary drug-eluting stents on the composite of cardiac death or myocardial infarction (MI) vs. medical therapy in patients with stable coronary lesions.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
